In our study, we found the compartmental localization of CD8+ and Foxp3+ cells might influence the impact of tumor immunity and only CD8+ cells in tumor area and Treg+ cells in surrounding stroma had relevance with clinical factors and tumor progression. The gene discussed is CD8A; the disease is neoplasm.